Najlepsi onkolodzy w Jerozolimie – TOP 14 lekarzy

Dr. Michael Lotem leads the Melanoma and Cancer Immunotherapy Center at Hadassah Medical Center. He specializes in advanced immunotherapy for melanoma. He is known for his research on SLAM receptors and their role in anti-cancer immune responses. Dr. Lotem has published widely in leading medical journals.

He heads a multidisciplinary team that uses clinical data and patient samples to advance research. Under his leadership, the center has improved patient outcomes with new therapies. The center is now recognized as a leader in cancer immunotherapy.

Dr. Auala Hubert is a board-certified medical oncologist and radiotherapist with 33 years of clinical experience. She works at Hadassah Medical Center and speaks both English and Hebrew. Dr. Hubert leads the Gastrointestinal Cancer Center. She is also a senior physician in the Oncology Department.

She earned her M.D. from Hadassah University Hospital. She holds board certifications in oncology and radiotherapy. Dr. Hubert has passed USMLE Parts I and II. She is a member of the Israel Society of Clinical Oncology, Israel Medical Society, and Israel Cancer Association. Dr. Hubert also serves on several medical and social service committees, where she helps advance cancer care.

RESEARCH ACTIVITY

1998–2000 — Conducted research on the genesis of cancer at The Royal Marsden Hospital (England).

PUBLICATIONS

Authored numerous peer-reviewed articles in scientific journals. Selected topics include:

Oncotype Dx Recurrence Score in BRCA1/2 germline mutation carriers with hormone receptor-positive breast cancer.

TP53 missense mutation recurrence in cancer patients of Arab descent.

Adjuvant autologous vaccine for stage III microscopic melanoma: biomarker survival and enhanced response to CTLA-4 blockade.

Prognostic significance of (R)CA15-3 assay in primary breast cancer.

Diagnostic and prognostic value of comparative thymidine kinase 1 (TK1) activity assays in breast cancer patient serum.

Complete remission in a BRCA2 mutation carrier with metastatic pancreatic adenocarcinoma treated with cisplatin.

Autologous vaccine-induced antitumor and self-reactive immune responses in melanoma: impact on patient survival and dependence on MHC class II expression.

PROFESSIONAL AFFILIATIONS

Israeli Society of Clinical Oncology

Israel Medical Association

AWARDS & GRANTS

Cancer Genetics Research Foundation Award

Landau Prize

Judith Segal Memorial Award

Core Specializations

Oncology:

Head and neck tumors

Thyroid cancer

Personalized biological and immunotherapy

Treatment of recurrent cancer and spinal metastases

Radiotherapy

Education

1998 — Graduated from the Faculty of Medicine at the Hebrew University (Jerusalem, Israel).
2016 — Six-month advanced training course in radiosurgery with a special focus on modern methods of focused radiotherapy for spinal and malignant thyroid tumors at Memorial Sloan Kettering Cancer Center (New York, USA).

Professional Experience

1998–1999 — Internship at Hadassah University Hospital (Jerusalem, Israel).
1999–2005 — Specialization in the Department of Otolaryngology and Head & Neck Surgery at Rabin Medical Center (Petah Tikva, Israel).
2005–2009 — Specialization in oncology and radiotherapy at the Davidoff Cancer Center (Rabin Medical Center).
2006–2008 — Fellowship at the University of Michigan (Ann Arbor, USA) in multidisciplinary cancer treatment.
2008 — Fellowship in head and neck tumor brachytherapy at Beth Israel Medical Center (New York, USA).
2009–2012 — Head of the Head and Neck Oncology Clinic at the Davidoff Cancer Center.
2013–2019 — Chief of the Head and Neck Oncology Division and Deputy Head of the Radiotherapy Department at the Davidoff Cancer Center.
Since 2019 — Director of the Oncology Department and Sharett Cancer Institute at Hadassah University Hospital.

Dr. Vladimir Yutkin, MD, is the Director of Urologic Oncology, Robotic, and Advanced Laparoscopic Surgery at Hadassah Medical Center. He has over 20 years of experience treating urological cancers. Dr. Yutkin also co-directs the Endo-Urology Society Fellowship. He is known for his expertise in minimally invasive surgical techniques.

Dr. Yutkin graduated from the Hebrew University of Jerusalem in 1996. He has performed many successful procedures, helping to improve patient survival and recovery. Dr. Yutkin speaks English, Hebrew, and Russian. He is a respected leader in urologic oncology.

KURSY EDUKACYJNE I SZKOLENIA ZAAWANSOWANE

• 1989 - uzyskał wyższe wykształcenie medyczne na Uniwersytecie Hebrajskim;
• 1995 – ukończył rezydenturę z zakresu chorób wewnętrznych i gastroenterologii w Szpitalu Uniwersyteckim Hadassah.
• 2001 - 2002 - Staż u profesora Scotta Friedmana w Katedrze Chorób Wątroby w Sinai School of Medicine w Nowym Jorku.

Dziś profesor Rifaat Safadi jest wybitnym specjalistą w dziedzinie leczenia chorób wątroby, członkiem komitetu ds. rozwoju ośrodka przeszczepu komórek somatycznych i kierownikiem oddziału chorób wątroby w Hadassah Medical Center. Profesor jest członkiem kilku międzynarodowych stowarzyszeń zajmujących się badaniem wątroby i autorem licznych artykułów w swojej specjalności. Profesor Safadi jest członkiem rady redakcyjnej naukowego czasopisma medycznego Clinical Science.

Rifaat Safadi jest laureatem wielu nagród naukowych. W szczególności wielokrotnie przyznawano mu Nagrodę Hadassah za badanie procesu immunomodulacji włóknienia wątroby przy użyciu mRNA. Za osiągnięcia w tej samej dziedzinie profesor otrzymał nagrody Sharon Donsky i Israeli Association of Gastroenterology and Hepatology.

Dr Beatrice Uziely jest doświadczoną specjalistką w dziedzinie raka, specjalizującą się w raku piersi, leczeniu przerzutów, stosowaniu hormonów i chemioterapii. Od 2001 roku jest kierownikiem oddziału onkologii w Hadassah Medical Center. Posiada dyplom z biologii i dyplom z medycyny z Uniwersytetu Hebrajskiego w Jerozolimie, a także specjalizację z onkologii i radioterapii onkologicznej. Jest autorką 59 publikacji poświęconych badaniom nad rakiem, ma 11 grantów i jest członkiem wielu stowarzyszeń zawodowych.

Kierownik Oddziału Chirurgii

Specjalizujemy się w leczeniu raka jelita grubego i nowotworów powierzchniowych

Dr Tamar Jablonski-Perec jest onkologiem w Hadassah Medical Center w Jerozolimie. Posiada tytuł doktora nauk medycznych Uniwersytetu Hebrajskiego i doświadczenie zdobyte w renomowanym Sloan-Kettering Cancer Center w Nowym Jorku. Jest kierownikiem Instytutu Onkologii, kierownikiem Breast Cancer Treatment Center i profesorem Wydziału Onkologii na Uniwersytecie Hebrajskim. Jest członkiem kilku międzynarodowych społeczności onkologicznych i otrzymała stypendium od Hadassah Medical School.

Dr. Alon Pikarsky is a board-certified general and colorectal surgeon at Hadassah Medical Center. He received his Israel Board Certification in General Surgery in 1998. He has led the Medical Students Program in Surgery since 1997. Since 2000, he has also served as Residency Program Director.

Dr. Pikarsky is known for his academic leadership. He has worked as an instructor in surgery since 1995, a lecturer since 1999, and a senior lecturer since 2005. He is an active member of several surgical associations. Dr. Pikarsky speaks both English and Hebrew fluently.

Dr. Michael Peer is a leading cardiothoracic specialist with more than 21 years of experience. He is the Senior Surgeon in the Thoracic Surgery Department at Ichilov Medical Center in Tel Aviv. Dr. Peer graduated from Tbilisi State Medical University. He also completed advanced training in thoracoscopic lung surgery at Cedars-Sinai Hospital in Los Angeles.

Dr. Peer has served as chief and senior surgeon at major hospitals in Israel, including Assaf Harofeh and Edith Wolfson Medical Centers. He has published over 20 scientific articles on lung cancer and thoracic diseases. He is also a frequent speaker at international medical conferences.